← Browse by Condition
Medical Condition

thromboembolic events

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 4
NCT02342444 Phase 4
Recruiting

Lovenox 30 mg Twice Daily (BID) Versus 40 mg Once Daily (QD)

Enrollment
606 pts
Location
United States
Sponsor
Oregon Health and Science Univ...
View Trial →